Bayesian Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bayesian Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35,900	Closed	-$356K	–	245
2025 Q3	$356K	Buy	35,900 +22,000	+158%	+$229K	0.07%	359
2025 Q2	$138K	Sell	13,900 -13,500	-49%	-$142K	0.02%	484
2025 Q1	$355K	Buy	+27,400	New	+$363K	0.06%	355
2022 Q4	–	Sell	-29,700	Closed	-$310K	–	841
2022 Q3	$310K	Buy	+29,700	New	+$387K	0.06%	404
2021 Q3	–	Sell	-21,148	Closed	-$208K	–	424
2021 Q2	$208K	Buy	21,148 +7,032	+50%	+$63.9K	0.05%	359
2021 Q1	$139K	Buy	+14,116	New	+$116K	0.03%	482
2020 Q4	–	Sell	-24,700	Closed	-$107K	–	511
2020 Q3	$107K	Buy	+24,700	New	+$176K	0.03%	478
2019 Q4	–	Sell	-22,849	Closed	-$82K	–	631
2019 Q3	$82K	Sell	22,849 -5,351	-19%	-$20.7K	0.02%	482
2019 Q2	$113K	Buy	+28,200	New	+$163K	0.02%	458

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bayesian Capital Management's DVAX Position: Q4 2025 in Review

Bayesian Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 35,900 shares — an estimated $356K sold.

Bayesian Capital Management first reported a position in DVAX in Q2 2019 and held it in 9 quarters. The position peaked at $356K in Q3 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

Bayesian Capital Management reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 35,900 Dynavax Technologies shares in Q4 2025, an estimated $356K.
Bayesian Capital Management first reported a position in Dynavax Technologies in Q2 2019 and held it in 9 quarters.
Bayesian Capital Management's Dynavax Technologies position peaked at $356K in Q3 2025.
266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.